Timothy P Heffernan - JoVE Visualize

Showing results (11-20 of 80) with videos related to

Pageof 8

Sort By:

DNA Repair|May 12, 2005

Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblastsNicole M King, Nana Nikolaishvili-Feinberg, Miriam F Bryant, et al.

Oncotarget|May 12, 2016

Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer modelsMichael S Lee, Timothy L Helms, Ningping Feng, et al.

Mutation Research|December 4, 2003

Caffeine and human DNA metabolism: the magic and the mysteryWilliam K Kaufmann, Timothy P Heffernan, Lea M Beaulieu, et al.

Oncogene|June 10, 2021

Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutationsMaryam Shariati, Kurt W Evans, Xiaofeng Zheng, et al.

Cancer Research|June 12, 2021

Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK InhibitionLiang Yan, Bo Tu, Jun Yao, et al.

Biorxiv : the Preprint Server for Biology|March 17, 2025

Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancerKrishnan K Mahadevan, Ana S Maldonado, Bingrui Li, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 17, 2011

Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinaseMasaoki Kawasumi, Bianca Lemos, James E Bradner, et al.

International Journal of Radiation Biology|February 20, 2020

Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpointsJessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.

Cancer Cell|April 9, 2008

Feedback circuit among INK4 tumor suppressors constrains human glioblastoma developmentRuprecht Wiedemeyer, Cameron Brennan, Timothy P Heffernan, et al.

Science Translational Medicine|March 15, 2019

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.

Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:

Pageof 8

DNA Repair|May 12, 2005

Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblastsNicole M King, Nana Nikolaishvili-Feinberg, Miriam F Bryant, et al.

Oncotarget|May 12, 2016

Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer modelsMichael S Lee, Timothy L Helms, Ningping Feng, et al.

Mutation Research|December 4, 2003

Caffeine and human DNA metabolism: the magic and the mysteryWilliam K Kaufmann, Timothy P Heffernan, Lea M Beaulieu, et al.

Oncogene|June 10, 2021

Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutationsMaryam Shariati, Kurt W Evans, Xiaofeng Zheng, et al.

Cancer Research|June 12, 2021

Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK InhibitionLiang Yan, Bo Tu, Jun Yao, et al.

Biorxiv : the Preprint Server for Biology|March 17, 2025

Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancerKrishnan K Mahadevan, Ana S Maldonado, Bingrui Li, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 17, 2011

Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinaseMasaoki Kawasumi, Bianca Lemos, James E Bradner, et al.

International Journal of Radiation Biology|February 20, 2020

Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpointsJessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.

Cancer Cell|April 9, 2008

Feedback circuit among INK4 tumor suppressors constrains human glioblastoma developmentRuprecht Wiedemeyer, Cameron Brennan, Timothy P Heffernan, et al.

Science Translational Medicine|March 15, 2019

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.

Pageof 8